Literature DB >> 10897849

[Asbestos and risk of cancer: exposure-effect relationships for occupationally exposed populations].

M Goldberg1.   

Abstract

For high levels of exposure (> 1 f/ml), the risk of lung cancer increases linearly with the cumulative exposure, and is the same for all types of asbestos; the risk of mesothelioma increases linearly with the level of exposure, is time dependent and higher for amphiboles. The effects of asbestos and smoking for lung cancer are independent, and the probability that a cancer is due to asbestos is the same among smokers and non-smokers. There is no scientific method for quantifying directly the risks associated to low levels of exposure (< 1 f/ml). The only possible approach is to extrapolate from the risks observed at high levels to low levels. Proportionality without threshold between dose and risk is not certain, but is the most plausible model. Using this model, one can expect about 30 additional cases of cancer for 10,000 men exposed at the level of 0.1 f/ml from 20 to 65 years, and about 16 additional cases for 10,000 women. These are high figures compared to other health hazards.

Entities:  

Mesh:

Year:  1999        PMID: 10897849

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  2 in total

1.  Prospective study of asbestos-related diseases incidence cases in primary health care in an area of Barcelona province.

Authors:  Magdalena Rosell-Murphy; Rafael Abós-Herràndiz; Josep Tarrés; Xavier Martínez-Artés; Isabel García-Allas; Ilona Krier; Gloria Cantarell; Miguel Gallego; Ramon Orriols; Constança Albertí
Journal:  BMC Public Health       Date:  2010-04-22       Impact factor: 3.295

2.  Risk factors associated with asbestos-related diseases: a community-based case-control study.

Authors:  Magdalena-Isabel Rosell-Murphy; Rafael Abós-Herràndiz; Josep Tarrés Olivella; Constança Alberti-Casas; Isabel García Allas; Xavier Martinez Artés; Ilona Krier Günther; Isidre Grimau Malet; Ramon Orriols Martínez; Jaume Canela-Soler
Journal:  BMC Public Health       Date:  2013-08-06       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.